Overbought and Overhauled: iShares MSCI World ETF Hits New Peak as Index Changes Loom

The iShares MSCI World ETF surges 33% to a fresh 52-week high, but a 94.6 RSI, new Fed chair Kevin Warsh, hot inflation, and an index overhaul signal looming headwinds.

The iShares MSCI World ETF punched through to a fresh 52-week high of $202.95 on Thursday, a 33% climb from its late-March trough. But the milestone comes with a flashing warning: the fund’s relative strength index has hit 94.6, deep in overbought territory. And the next fortnight promises no respite, as the ETF barrels into a confluence of macro shocks, a new Federal Reserve chair, and a major index reconstruction.

Inflation and a New Sheriff at the Fed

The macro picture is turning hostile for growth stocks. US consumer prices rose 3.8% in April from a year earlier, the hottest reading since May 2023, driven largely by a 3.8% monthly surge in energy costs linked to the war with Iran. That single category accounted for more than 40% of the overall increase. Producer prices jumped 6% year-on-year, well above the 4.8% forecast, pouring cold water on hopes for rate cuts this year.

Meanwhile, the Fed is about to change leadership. The Senate voted 54-45 to confirm Kevin Warsh as the next chair, replacing Jerome Powell, whose term ends on May 15. Powell will remain on the Board of Governors—a rare holdover not seen in 75 years. Warsh has promised “messier” policy meetings, arguing that a “good family fight” can sharpen economic decisions. Already three committee members have hinted that the next move could be a hike. Futures markets now price in a roughly 30% chance of a rate increase by year-end.

Index Overhaul Adds Mechanical Pressure

On May 12, MSCI announced the results of its semi-annual index review, with changes set to take effect at the close of trading on May 29. For the MSCI World Index, Medline A, MasTec, and TechnipFMC are the largest additions by market capitalisation. The broader MSCI ACWI will see 49 additions and 101 deletions, while the MSCI World All Cap Index adds 144 securities and removes 81. That means the ETF—a physical replicator—must execute a wave of purchases and sales to stay aligned with its benchmark.

Adding to the complexity, a refined free-float methodology kicks in on June 1, forcing further adjustments. The rebalancing alone could inject volatility into a fund already trading at stretched valuations.

Tech Dominance Leaves Little Room for Error

Technology stocks account for about 29% of the portfolio, with Nvidia as the top holding at roughly 6%, followed by Apple at 4.58% and Microsoft at 3.31%. The ten largest positions—including Amazon, Alphabet, and Meta—concentrate roughly 27% of assets. That narrow base has been a boon for performance: the NAV total return stood at 8.04% as of May 12. But it also makes the fund acutely sensitive to rising discount rates and any geopolitical shock to chip exports—a risk highlighted by the upcoming Trump-Xi summit in Beijing.

The healthcare sector adds another layer of uncertainty. Exposure sits at around 10% of the portfolio, but the US government is planning a 15% tariff on patented drugs from Europe and Asia starting in late July. British products would face a 10% levy. For companies without pre-existing pricing agreements, tariffs could climb to 100%. FactSet has already trimmed earnings estimates for the sector.

Fee Pressure Mounts Despite Steady Flows

BlackRock charges 0.24% for the iShares MSCI World ETF, but Invesco recently slashed the fee on a rival global product to 0.05%—a 19-basis-point gap. So far, investors have been willing to pay the premium: the fund attracted $770 million in inflows and now manages roughly $8.25 billion in total assets. Whether that tolerance holds as the market re-rates risk in a higher-for-longer rate environment remains an open question.

For now, the ETF sits at a record, but the forces bearing down on it are anything but benign. Inflation is sticky, the Fed is pivoting, and the index itself is being reshuffled. The next few weeks will test whether the rally has legs—or whether the overbought RSI was the first crack in the facade.